Project 2026-01956

2026-01956
A Phase 2 study of intratumoral administration of L19IL2/L19TNF in locally advanced Cutaneous Squamous Cell Carcinoma patients progressing on or intolerant to systemic treatment
multicentric
Rebekka Pia Mendez Lopez
Kantonspital St. Gallen, St Gallen
lstituto Oncologico Svizzera ltaliana-I0SI, Bellinzona
University Hospital Zurich, Zurich-Flughafen
clinical trial
phase 2
C
Ethikkommission Ostschweiz (EKOS)
Kantonale Ethikkommission Zürich, Comitato etico cantonale Ticino
29.10.2026
Philogen S.p.A.
drugs